Sign In

Login to the AMI Physician Center

Headline news:

Women & Heart Disease: Heart Attacks Without Chest... [Learn More]
AMI Foundation 2nd Annual Fashion Show and Luncheon      ... [Learn More]
A Clinician’s Guide to Lung Cancer Screening with Low Dose CT    ... [Learn More]
Atlantic Medical Imaging Introduces Powerful New Weapon in Battle against Lung Cancer. ... [Learn More]
Fellowship trained women's imager joins Atlantic Medical Imaging ... [Learn More]
SJ Top Docs for 2011 ... [Learn More]
Atlantic Medical Imaging is pleased to announce the launch of their Facebook page. ... [Learn More]
A Little Exercise Can Go A Long Way, Study Shows. ... [Learn More]
CT Lung Cancer Screenings show 20% reduction in lung cancer deaths. ... [Learn More]

Cardiac Imaging Center of Excellence

You could spend a lifetime worrying about your heart or in a few minutes find out if you really have to worry at all. The most effective treatment for heart disease is prevention. The earlier heart disease can be detected the sooner you can begin modifying your risk factors. For many people there are no warning signs of heart attacks. Half of the people who suffer heart attacks have normal levels of cholesterol and/or normal blood pressure. For over 150,000 Americans per year, the very first sign of coronary artery disease is sudden death.
Atlantic Medical Imaging has one of New Jersey’s most advanced cardiovascular imaging programs, providing comprehensive multimodality imaging for the full range of cardiovascular issues.

In 2001, AMI introduced coronary CT Angiography (CCTA), technologically the most advanced non-invasive CT exam for detecting coronary artery disease available in the world. Since then, AMI has accumulated one of the world’s largest case experiences of more than 10,000 examinations, setting the standard of excellence in coronary CTA.

With this groundbreaking technology, which provides unprecedented image quality, we are able to non-invasively capture images of the coronary arteries in fewer than five heartbeats. In 2007, AMI, in conjunction with GE Healthcare, developed Prospectively Gated coronary CTA. With this new technology, the radiation dose is dramatically reduced without compromising the image quality.

 

CONTINUE  >